United States Other Joint Reconstruction Market Outlook to 2025 - Ankle Replacement, Digits Replacement, Elbow Replacement and Wrist Replacement

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Other Joint Reconstruction Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Other Joint Reconstruction Market, United States, Revenue ($m), 2015-2025
3.1.1 Ankle Replacement Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.2 Digits Replacement Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.3 Elbow Replacement Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.4 Wrist Replacement Market, United States, Revenue ($m), by Segment, 2015-2025
3.2 Other Joint Reconstruction Market, United States, Volume (Units), 2015-2025
3.2.1 Ankle Replacement Market, United States, Volume (Units), by Segment, 2015-2025
3.2.2 Digits Replacement Market, United States, Volume (Units), by Segment, 2015-2025
3.2.3 Elbow Replacement Market, United States, Volume (Units), by Segment, 2015-2025
3.2.4 Wrist Replacement Market, United States, Volume (Units), by Segment, 2015-2025
3.3 Other Joint Reconstruction Market, United States, Average Price ($), 2015-2025
3.4 Other Joint Reconstruction Market, United States, Distribution Share by Revenue ($m), 2019
3.5 Other Joint Reconstruction Market, United States, Company Share by Revenue ($m), 2019

4.1 Stryker Corp
4.1.1 Company Overview
4.2 Wright Medical Group NV
4.2.1 Company Overview
4.3 Zimmer Biomet Holdings Inc
4.3.1 Company Overview
4.4 Exactech Inc
4.4.1 Company Overview
4.5 Limacorporate SpA
4.5.1 Company Overview
4.6 KLS Martin LP
4.6.1 Company Overview
4.7 Integra LifeSciences Corp
4.7.1 Company Overview

6.1 Debt Offerings
6.1.1 Stryker Prices USD600 Million in Public Offering of 0.600% Senior Notes Due 2023
6.1.2 Stryker Raises USD650 Million in Public Offering of 1.15% Notes Due 2025
6.1.3 Stryker Raises USD1 Billion in Public Offering of 1.95% Notes Due 2030
6.1.4 Stryker Raises USD650 Million in Public Offering of 2.9% Notes Due 2050
6.1.5 Zimmer Biomet Prices Public Offering of 3.55% Notes Due 2030 for USD900 Million
6.1.6 Zimmer Biomet Prices Public Offering of 3.05% Notes Due 2026 for USD600 Million
6.1.7 Integra LifeSciences Prices Private Placement of 0.5% Convertible Senior Notes Due 2025 for USD500 Million
6.2 Equity Offerings
6.2.1 SINTX Technologies Plans to Raise up to USD75 Million in Public Offering of Securities
6.2.2 ConforMIS Prices Private Placement of Units for USD17.2 Million
6.2.3 ConforMIS Plans to Raise up to USD25 Million in Public Offering of Shares
6.2.4 SINTX Technologies to Raise USD8.19 Million in Public Offering of Shares
6.2.5 SINTX Technologies Prices Private Placement of Shares for USD3 Million
6.2.6 SINTX Technologies to Raise USD41.3 Million in Public offering of Shares
6.2.7 SINTX Technologies Prices Private Placement of Shares for USD5.6 Million
6.2.8 OrthoPediatrics Raises USD75.2 Million in Public Offering of Shares
6.2.9 Conformis Files Registration Statement for Public Offering of Securities up to USD200 Million
6.2.10 Sintx Technologies to Raise USD8.8 million in Rights Offering
6.3 Venture Financing
6.3.1 Bio2 Technologies Raises USD3.2 Million in Venture Financing
6.3.2 OrthAlign Raises USD11.2 Million in Venture Financing

7.1 Corporate Communications
7.1.1 Mar 02, 2020: Stryker announces new Investor Relations leader
7.1.2 Feb 25, 2020: Stryker announces nomination of new Director, Lisa Skeete Tatum
7.1.3 Feb 05, 2020: Conformis appoints Bob Howe as Chief Financial Officer
7.2 Financial Announcements
7.2.1 Feb 20, 2020: LX Analyzer successfully detects Coronavirus RNA
7.2.2 Feb 19, 2020: Integra LifeSciences reports fourth quarter and full-year 2019 financial results and provides 2020 financial guidance
7.2.3 Feb 04, 2020: Zimmer Biomet announces fourth quarter and full-year 2019 financial results
7.2.4 Jan 28, 2020: Stryker reports 2019 results and 2020 outlook
7.2.5 Jan 24, 2020: The first patient included in Australia in Isofol's phase 3 AGENT study
7.2.6 Jan 14, 2020: Conformis reports preliminary fourth quarter and year-end 2019 revenue results
7.2.7 Jan 13, 2020: OrthoPediatrics reports preliminary unaudited revenue for fourth quarter and record setting full year 2019
7.3 Other Significant Developments
7.3.1 Aug 20, 2020: Conformis Announces achievement of second milestone under development and license agreements
7.3.2 Jun 29, 2020: DePuy Synthes renews cooperation agreement with AO Foundation to continue advancement of surgical education
7.3.3 May 28, 2020: Conformis announces settlement of patent dispute
7.4 Strategy And Business Planning
7.4.1 Feb 20, 2020: Galderma announces New England Journal of Medicine publication from phase 2 study of investigational therapy Nemolizumab in patients with moderate to severe Prurigo Nodularis

8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 Consulting
8.3 Contact the Publisher
8.4 Disclaimer

Table 1: Other Joint Reconstruction Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 2: Other Joint Reconstruction Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 3: Ankle Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 4: Ankle Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 5: Digits Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 6: Digits Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 7: Elbow Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 8: Elbow Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 9: Wrist Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 10: Wrist Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 11: Other Joint Reconstruction Market, United States, Volume (Units), 2015-2020
Table 12: Other Joint Reconstruction Market, United States, Volume (Units), 2021-2025
Table 13: Ankle Replacement Market, United States, Volume (Units), 2015-2020
Table 14: Ankle Replacement Market, United States, Volume (Units), 2021-2025
Table 15: Digits Replacement Market, United States, Volume (Units), 2015-2020
Table 16: Digits Replacement Market, United States, Volume (Units), 2021-2025
Table 17: Elbow Replacement Market, United States, Volume (Units), 2015-2020
Table 18: Elbow Replacement Market, United States, Volume (Units), 2021-2025
Table 19: Wrist Replacement Market, United States, Volume (Units), 2015-2020
Table 20: Wrist Replacement Market, United States, Volume (Units), 2021-2025
Table 21: Other Joint Reconstruction Market, United States, Average Price ($), 2015-2020
Table 22: Other Joint Reconstruction Market, United States, Average Price ($), 2021-2025
Table 23: Other Joint Reconstruction Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019
Table 24: Other Joint Reconstruction Market, United States, Company Share by Revenue ($m), USD Constant, 2019
Table 25: Other Joint Reconstruction Market Pipeline Products
Table 26: Stryker Prices USD600 Million in Public Offering of 0.600% Senior Notes Due 2023
Table 27: Stryker Raises USD650 Million in Public Offering of 1.15% Notes Due 2025
Table 28: Stryker Raises USD1 Billion in Public Offering of 1.95% Notes Due 2030
Table 29: Stryker Raises USD650 Million in Public Offering of 2.9% Notes Due 2050
Table 30: Zimmer Biomet Prices Public Offering of 3.55% Notes Due 2030 for USD900 Million
Table 31: Zimmer Biomet Prices Public Offering of 3.05% Notes Due 2026 for USD600 Million
Table 32: Integra LifeSciences Prices Private Placement of 0.5% Convertible Senior Notes Due 2025 for USD500 Million
Table 33: SINTX Technologies Plans to Raise up to USD75 Million in Public Offering of Securities
Table 34: ConforMIS Prices Private Placement of Units for USD17.2 Million
Table 35: ConforMIS Plans to Raise up to USD25 Million in Public Offering of Shares
Table 36: SINTX Technologies to Raise USD8.19 Million in Public Offering of Shares
Table 37: SINTX Technologies Prices Private Placement of Shares for USD3 Million
Table 38: SINTX Technologies to Raise USD41.3 Million in Public offering of Shares
Table 39: SINTX Technologies Prices Private Placement of Shares for USD5.6 Million
Table 40: OrthoPediatrics Raises USD75.2 Million in Public Offering of Shares
Table 41: Conformis Files Registration Statement for Public Offering of Securities up to USD200 Million
Table 42: Sintx Technologies to Raise USD8.8 million in Rights Offering
Table 43: Bio2 Technologies Raises USD3.2 Million in Venture Financing
Table 44: OrthAlign Raises USD11.2 Million in Venture Financing
Table 45: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

Figure 1: Other Joint Reconstruction Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Ankle Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 3: Digits Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 4: Elbow Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 5: Wrist Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 6: Other Joint Reconstruction Market, United States, Volume (Units), 2015-2025
Figure 7: Ankle Replacement Market, United States, Volume (Units), 2015-2025
Figure 8: Digits Replacement Market, United States, Volume (Units), 2015-2025
Figure 9: Elbow Replacement Market, United States, Volume (Units), 2015-2025
Figure 10: Wrist Replacement Market, United States, Volume (Units), 2015-2025
Figure 11: Other Joint Reconstruction Market, United States, Company Share (%) 2019